These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8993841)

  • 1. Molecular determinants of peptide and non-peptide binding to the AT1 receptor.
    Karnik SS; Husain A; Graham RM
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S58-66. PubMed ID: 8993841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of peptide and non-peptide binding to the AT1 receptor.
    Karnik SS; Husain A; Graham RM
    Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S58-66. PubMed ID: 21143275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The docking of Arg2 of angiotensin II with Asp281 of AT1 receptor is essential for full agonism.
    Feng YH; Noda K; Saad Y; Liu XP; Husain A; Karnik SS
    J Biol Chem; 1995 May; 270(21):12846-50. PubMed ID: 7759541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms.
    Noda K; Saad Y; Kinoshita A; Boyle TP; Graham RM; Husain A; Karnik SS
    J Biol Chem; 1995 Feb; 270(5):2284-9. PubMed ID: 7530721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Phe8 of angiotensin II with Lys199 and His256 of AT1 receptor in agonist activation.
    Noda K; Saad Y; Karnik SS
    J Biol Chem; 1995 Dec; 270(48):28511-4. PubMed ID: 7499361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan.
    Ji H; Leung M; Zhang Y; Catt KJ; Sandberg K
    J Biol Chem; 1994 Jun; 269(24):16533-6. PubMed ID: 8206967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants.
    Monnot C; Bihoreau C; Conchon S; Curnow KM; Corvol P; Clauser E
    J Biol Chem; 1996 Jan; 271(3):1507-13. PubMed ID: 8576145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor.
    Perlman S; Schambye HT; Rivero RA; Greenlee WJ; Hjorth SA; Schwartz TW
    J Biol Chem; 1995 Jan; 270(4):1493-6. PubMed ID: 7829475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computer modeling postulated mechanism for angiotensin II receptor activation.
    Joseph MP; Maigret B; Bonnafous JC; Marie J; Scheraga HA
    J Protein Chem; 1995 Jul; 14(5):381-98. PubMed ID: 8590606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interactions of L-162,313 with angiotensin II receptor subtypes and mutants.
    Vianello B; Clauser E; Corvol P; Monnot C
    Eur J Pharmacol; 1998 Apr; 347(1):113-8. PubMed ID: 9650856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of a non-peptide agonist with angiotensin II AT1 receptor mutants.
    Costa-Neto CM; Miyakawa AA; Pesquero JB; Oliveira L; Hjorth SA; Schwartz TW; Paiva AC
    Can J Physiol Pharmacol; 2002 May; 80(5):413-7. PubMed ID: 12056547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that [Sar1]angiotensin II behaves differently from angiotensin II at angiotensin AT1 receptors in rabbit aorta.
    Liu YJ
    Eur J Pharmacol; 1993 Apr; 235(1):9-15. PubMed ID: 8519284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of valsartan to mammalian angiotensin AT1 receptors.
    de Gasparo M; Whitebread S
    Regul Pept; 1995 Nov; 59(3):303-11. PubMed ID: 8577935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells.
    Chansel D; Bizet T; Vandermeersch S; Pham P; Levy B; Ardaillou R
    Am J Physiol; 1994 Mar; 266(3 Pt 2):F384-93. PubMed ID: 8160786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization of the rat AT1a and AT1b receptors: pharmacological and functional requirements.
    Conchon S; Monnot C; Teutsch B; Corvol P; Clauser E
    FEBS Lett; 1994 Aug; 349(3):365-70. PubMed ID: 8050598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the AT1 angiotensin II receptor expressed in guinea pig liver.
    García-Sáinz JA; Martínez-Alfaro M; Romero-Avila MT; González-Espinosa C
    J Endocrinol; 1997 Jul; 154(1):133-8. PubMed ID: 9246947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature.
    Zhuo J; Dean R; MacGregor D; Alcorn D; Mendelsohn FA
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S147-54. PubMed ID: 8993855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
    Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
    J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of AT1 receptors in the central control of sympathetic vasomotor function.
    Head GA
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S93-8. PubMed ID: 8993846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning of the canine angiotensin II receptor. An AT1-like receptor with reduced affinity for DuP753.
    Burns L; Clark KL; Bradley J; Robertson MJ; Clark AJ
    FEBS Lett; 1994 Apr; 343(2):146-50. PubMed ID: 8168620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.